Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.88 -0.08 (-8.65%)
As of: Sep 30, 2026 · 2:36 PM EDT

Alaunos Therapeutics (TCRT) Total Debt (2021 - 2023)

Updated

Alaunos Therapeutics (TCRT) reported Total Debt of $10.99 million for Q1 2023, down 54.8% from $24.32 million a year earlier and down 34.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Total Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Alaunos Therapeutics posted Total Debt of $16.77 million, down 30.5% from FY2021.

  • By year, Total Debt came in at $24.12 million in FY2021.
  • Year over year, Total Debt has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q1 2023 came in at $16.77 million (Q4 2022), $22.67 million (Q3 2022) and $24.52 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 49.04 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 70.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -111.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Alaunos Therapeutics 2.39 Mn -1.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 10.99 Mn
Dec 31, 2022 16.77 Mn
Sep 30, 2022 22.67 Mn
Jun 30, 2022 24.52 Mn
Mar 31, 2022 24.32 Mn
Dec 31, 2021 24.12 Mn
Sep 30, 2021 24.21 Mn
API Access

Alaunos Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=TCRT&period=max&api_key=YOUR_API_KEY